Gut microbiota ecosystem and Clostridioides difficile

The gut microbiota ecosystem is a diverse community of microorganisms that maintains intestinal homeostasis and provides colonization resistance against opportunistic pathogens like Clostridioides difficile [1]. C. difficile is a gram-positive, spore-forming anaerobe that can proliferate and produce toxins when the normal flora is disrupted, typically by broad-spectrum antibiotic use [3]. This disruption alters the metabolic environment, specifically reducing the conversion of primary bile acids to secondary bile acids, which are essential for inhibiting C. difficile germination and growth [4]. Therapeutic strategies targeting this ecosystem include the use of narrow-spectrum antibiotics like fidaxomicin to eradicate the pathogen while sparing commensal bacteria, and live biotherapeutic products like Vowst or Rebyota to restore microbial diversity [2]. Additionally, monoclonal antibodies such as bezlotoxumab are used to neutralize C. difficile Toxin B, reducing the risk of recurrent infection [5]. The successful management of this ecosystem is vital for treating pseudomembranous colitis and preventing the cycle of recurrent C. difficile infection [1].

Other names

Gut microbiomeIntestinal microbiotaC. diffClostridium difficileCDIAntibiotic-associated colitis

Restoration of colonization resistance and competitive exclusion of pathogens, alongside direct inhibition of bacterial growth and neutralization of secreted toxins.